arrow
J

Joanne L. Blum

ut md anderson cancer center
H指数:33
被引数:9,305

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness of palbociclib plus hormone treatment and its impact on patient quality of life: a plain language summary of findings from POLARIS

帕博西利联合激素治疗的真实世界有效性与对生活质量的影响:POLARIS研究结果的大众语言摘要

2025-10-270
OAAI
Enhancing the interpretation of real-world quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer enrolled in the POLARIS study

增强POLARIS研究中激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者现实世界生活质量解释

2025-10-010
OA
Real-world quality-of-life of patients with HR+/HER2-advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS

接受palbociclib加内分泌治疗的HR /HER2-advanced乳腺癌患者的现实生活质量: 北极星的EORTC QLQ-C30结果

2024-11-251
OAAI
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status
2024-06-137
OAAI
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
LANCET
IF88.5
2023-04-0159
OAAI
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving the Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib: Biomarker Results from POLARIS
2023-03-010
PRE
Real-world quality of life (QoL) in patients with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-), advanced breast cancer (ABC) treated with palbociclib: A patient-reported outcome (PRO) analysis from POLARIS
2022-02-152
PRE